The following is a summary of “Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with ...

City Therapeutics will develop a novel RNAi clinical candidate toward a specific disease target for intravitreal ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces it has submitted a ...

In this video, Clement K. Chan, MD, FACS, discusses highlights from the AAO meeting, including presentations on pegcetacoplan and avacincaptad pegol for the treatment of geographic atrophy.In addition ...

While much attention is given to the painful crises, anaemia, and organ damage caused by SCD, its impact on vision is equally ...

Vitamin A is a key component in rhodopsin, a light-sensitive protein that helps in producing pigments in the retina, which help with vision in low light areas.

These glasses allow people with macular degeneration to see complete objects by banishing pesky blind spots using dozens of ...

Our goal is to confirm the safety of our drug candidate to then rapidly move into a Phase II proof-of-concept study, to demonstrate transferrin's ability to protect retinal cells from atrophy and ...

Geographic atrophy, also known as GA, is a form of advanced dry macular degeneration where patients can develop vision loss from areas of retinal cell death that enlarge over time. If left ...

Geographic atrophy, also known as GA, is a form of advanced dry macular degeneration where patients can develop vision loss from areas of retinal cell death that enlarge over time. If left ...